Recombinant human growth hormone increases thyroid hormone-binding sites in recovering severely burned children.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.

T4 and T3 are carried on serum transport proteins via thyroid hormone-binding sites (THBS).

This study investigated the effect of rhGH on THBS sites in burned children.

Who Took Part

According to the abstract, 11 children were involved.

The age groups tagged for this paper are children.

How the Study Was Run

The design is described as randomized and placebo-controlled.

Because people in this Exogenous HGH, sermorelin & older GHRPs (why they're passed over) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

A placebo (an inactive look-alike) gave the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group a baseline to be compared against.

What Was Measured

PubMed files the paper under topics including Blood Glucose, Burns, Human Growth Hormone, Insulin-Like Growth Factor Binding Protein 3, Prealbumin, Serum Albumin and Thyroxine.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in 11 children.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2003 (Shock (Augusta, Ga.)), a journal based in United States.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.